These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 21035624

  • 1. A positron emission tomography study examining the dopaminergic activity of armodafinil in adults using [¹¹C]altropane and [¹¹C]raclopride.
    Spencer TJ, Madras BK, Bonab AA, Dougherty DD, Clarke A, Mirto T, Martin J, Fischman AJ.
    Biol Psychiatry; 2010 Nov 15; 68(10):964-70. PubMed ID: 21035624
    [Abstract] [Full Text] [Related]

  • 2. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro.
    Madras BK, Xie Z, Lin Z, Jassen A, Panas H, Lynch L, Johnson R, Livni E, Spencer TJ, Bonab AA, Miller GM, Fischman AJ.
    J Pharmacol Exp Ther; 2006 Nov 15; 319(2):561-9. PubMed ID: 16885432
    [Abstract] [Full Text] [Related]

  • 3. Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications.
    Volkow ND, Fowler JS, Logan J, Alexoff D, Zhu W, Telang F, Wang GJ, Jayne M, Hooker JM, Wong C, Hubbard B, Carter P, Warner D, King P, Shea C, Xu Y, Muench L, Apelskog-Torres K.
    JAMA; 2009 Mar 18; 301(11):1148-54. PubMed ID: 19293415
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Understanding the central pharmacokinetics of spheroidal oral drug absorption system (SODAS) dexmethylphenidate: a positron emission tomography study of dopamine transporter receptor occupancy measured with C-11 altropane.
    Spencer TJ, Bonab AA, Dougherty DD, Mirto T, Martin J, Clarke A, Fischman AJ.
    J Clin Psychiatry; 2012 Mar 18; 73(3):346-52. PubMed ID: 22154896
    [Abstract] [Full Text] [Related]

  • 6. Dopamine transporter-related effects of modafinil in rhesus monkeys.
    Andersen ML, Kessler E, Murnane KS, McClung JC, Tufik S, Howell LL.
    Psychopharmacology (Berl); 2010 Jun 18; 210(3):439-48. PubMed ID: 20386883
    [Abstract] [Full Text] [Related]

  • 7. Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder.
    Schneier FR, Abi-Dargham A, Martinez D, Slifstein M, Hwang DR, Liebowitz MR, Laruelle M.
    Depress Anxiety; 2009 Jun 18; 26(5):411-8. PubMed ID: 19180583
    [Abstract] [Full Text] [Related]

  • 8. Sex differences in striatal dopamine release in young adults after oral alcohol challenge: a positron emission tomography imaging study with [¹¹C]raclopride.
    Urban NB, Kegeles LS, Slifstein M, Xu X, Martinez D, Sakr E, Castillo F, Moadel T, O'Malley SS, Krystal JH, Abi-Dargham A.
    Biol Psychiatry; 2010 Oct 15; 68(8):689-96. PubMed ID: 20678752
    [Abstract] [Full Text] [Related]

  • 9. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis.
    Tsukada H, Harada N, Nishiyama S, Ohba H, Sato K, Fukumoto D, Kakiuchi T.
    Synapse; 2000 Aug 15; 37(2):95-103. PubMed ID: 10881030
    [Abstract] [Full Text] [Related]

  • 10. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L.
    Biol Psychiatry; 2005 Feb 01; 57(3):229-38. PubMed ID: 15691523
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse.
    Loland CJ, Mereu M, Okunola OM, Cao J, Prisinzano TE, Mazier S, Kopajtic T, Shi L, Katz JL, Tanda G, Newman AH.
    Biol Psychiatry; 2012 Sep 01; 72(5):405-13. PubMed ID: 22537794
    [Abstract] [Full Text] [Related]

  • 13. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.
    Pellegrino D, Cicchetti F, Wang X, Zhu A, Yu M, Saint-Pierre M, Brownell AL.
    J Nucl Med; 2007 Jul 01; 48(7):1147-53. PubMed ID: 17574972
    [Abstract] [Full Text] [Related]

  • 14. Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane.
    Spencer TJ, Biederman J, Madras BK, Dougherty DD, Bonab AA, Livni E, Meltzer PC, Martin J, Rauch S, Fischman AJ.
    Biol Psychiatry; 2007 Nov 01; 62(9):1059-61. PubMed ID: 17511972
    [Abstract] [Full Text] [Related]

  • 15. The unique psychostimulant profile of (±)-modafinil: investigation of behavioral and neurochemical effects in mice.
    Mereu M, Chun LE, Prisinzano TE, Newman AH, Katz JL, Tanda G.
    Eur J Neurosci; 2017 Jan 01; 45(1):167-174. PubMed ID: 27545285
    [Abstract] [Full Text] [Related]

  • 16. Dopamine Transporter Correlates and Occupancy by Modafinil in Cocaine-Dependent Patients: A Controlled Study With High-Resolution PET and [(11)C]-PE2I.
    Karila L, Leroy C, Dubol M, Trichard C, Mabondo A, Marill C, Dubois A, Bordas N, Martinot JL, Reynaud M, Artiges E.
    Neuropsychopharmacology; 2016 Aug 01; 41(9):2294-302. PubMed ID: 26892922
    [Abstract] [Full Text] [Related]

  • 17. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
    Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, Wong C, Swanson JM.
    Arch Gen Psychiatry; 2007 Aug 01; 64(8):932-40. PubMed ID: 17679638
    [Abstract] [Full Text] [Related]

  • 18. Measurement of psychological state changes at low dopamine transporter occupancy following a clinical dose of mazindol.
    Kimura Y, Maeda J, Yamada M, Takahata K, Yokokawa K, Ikoma Y, Seki C, Ito H, Higuchi M, Suhara T.
    Psychopharmacology (Berl); 2017 Feb 01; 234(3):323-328. PubMed ID: 27766370
    [Abstract] [Full Text] [Related]

  • 19. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K, Johansson JJ, Tuokkola T, Någren K, Rinne JO.
    Neuroimage; 2013 Nov 15; 82():252-9. PubMed ID: 23727314
    [Abstract] [Full Text] [Related]

  • 20. In vivo quantification of striatal dopamine D2 receptor occupancy by JNJ-37822681 using [11C]raclopride and positron emission tomography.
    te Beek ET, de Boer P, Moerland M, Schmidt ME, Hoetjes NJ, Windhorst AD, van Berckel BN, Cohen AF, van Gerven JM, Lammertsma AA.
    J Psychopharmacol; 2012 Aug 15; 26(8):1128-35. PubMed ID: 22290934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.